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Cyclic nucleotide phosphodiesterases in glomeruli of rat renal
cortex. The presence and properties of cyclic 3' ,5'-adenosine
monophosphate phosphodiesterase (cAMP-PDIE) and cyclic
3' ,5'-guanosine monophosphate phosphodiesterase (cGMP-
PDIE) were studied in glomeruli isolated from rat renal cortex by
sieving and density gradient centrifugation. The specific activity
of cGMP-PDIE was higher than the specific activity of cAMP-
PDIE in glomeruli; in tubules and renal cortical slices, the specif-
ic activity of cAMP-PDIE was higher than that of cGMP-PDIE.
In homogenates, > lOO,000g supernate of homogenate (cytosol)
and x 100,000g pellet (membrane fraction) from glomeruli, the
specific activity of cGMP-PDIE was significantly higher than it
was in analogous preparations from tubules or renal cortical
slices. Cyclic 3' ,5'-GMP (l06M to l0M) stimulated glomerular
cAMP-PDIE, but it was without effect on cAMP-PDIE from tu-
bules. Structural analogs of cyclic 3' ,5'-GMP or 5'-GMP did not
stimulate glomerular cAMP-PDIE. Cyclic 3',5'-AMP slightly in-
hibited cGMP-PDIE from both glomeruli and tubules. N6-,2'-O-
dibutyryl cyclic 3' ,5'-AMP inhibited cAMP-PDIE, but not
cGMP-PDIE. The addition of calcium increased the activity of
cGMP-PDIE, mainly in tubules, but was without effect on
cAMP-PDIE. These results suggest the predominance of cyclic
3' ,5'-GMP catabolism in glomeruli in comparison with other cor-
tical structures, and they demonstrate that both the specific ac-
tivities and regulatory properties of cyclic nucleotide phospho-
diesterase in glomeruli differ markedly from tubules or unfraction-
ated renal cortical tissue.
Phosphodiestérases des nucléotides cycliques dans les glomé-
rules du cortex de rat. La presence et les propriétés de Ia
phosphodiestérase 3',5'-cAMP (cAMP-PDIE) et de Ia phospho-
diestérase 3',5'-GMP cyclique (cGMP-PDIE) ont été étudiées
dans les glomérules isolés du cortex renal de rat par filtration et
centrifugation en gradient de densité. L'activité spécifique de
cGMP-PDIE est plus grande que celle de cAMP-PDIE dans les
glomérules. Dans les tubes et les tranches de cortex renal
l'activité specifique de cAMP-PDIE est plus élevée que celle de
cGMP-PDIE. Dans les homogenats, Ic surnageant x lOO,000g
(cytosol) et le culot x lOO,000g (fraction membranaire) ont des
actIvités spécifiques plus élevées pour cGMP-PDIE pour les
preparations de glomérules que pour celles de tubes ou de
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tranches de cortex. Le 3',5'-GMP cyclique (l06M a 105M) stim-
ule le cAMP-PDIE glomérulaire mais est sans effet sur Ic
cAMP-PDIE des tubes. Les analogues de structure du 3',5'-
GMP cyclique ou le 5'-GMP ne stimulent pas Ic cAMP-PDIE
glomérulaire. Le 3',5'-AMP cyclique inhibe faiblement cGMP-
PDIE des glomérules et des tubes. Le N-,2'-O-dibutyryl 3,5'-
AMP cyclique inhibe cAMP-PDIE mais pas cGMP-PDIE.
L'addition de calcium augmente cGMP-PDIE, surtout dans les
tubes, mais est sans effet sur cAMP-PDIE. Ces résultats sug-
gèrent Ia predominance du catabolisme du 3' ,5'-GMP dans les
glomérules, par comparaison avec les autres structures corti-
cales et démontre qu'à Ia fois les activités spécifiques et les
propriétés de regulation des PDIE sont notoirement différentes
dans les glomérules par rapport aux tubes ou au tissu cortical
renal.
In the past, renal metabolism has been studied in
the whole kidney or in gross anatomical sub-
divisions of renal tissue such as cortex, medulla,
and papilla [1—5]. These subsections of the kidney
are, in turn, composed of functionally and structur-
ally different parts of the nephron. Since tubules
represent about 92% of the renal cortical tissue vol-
ume [61, it is likely that studies using whole renal
cortical tissue would reflect factors of cyclic nude-
otide metabolism in cortical tubules rather than in
glomeruli.
Several recent findings suggest that cyclic nude-
otide content and metabolism in glomeruli differ
from that in cortical tubules, Recently, we found
that glomeruli have a higher content of immuno-
reactive cyclic guanosine monophosphate (cGMP)
than do tubules, although the content of immuno-
reactive cAMP appears to be about equal in glomer-
uli and tubules [7]. Concerning cyclic nucleotide
biosynthesis, it has been reported that glomeruli
isolated from rabbit kidney cortex contain a much
higher activity of quanylate cyclase than do tubular
structures from the same tissue [81. Hormone-sensi-
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tive adenylate cyclase has also been described in
glomeruli of rabbit [91 and rat [10, 111.
Based on the findings mentioned above [7—111
and on studies of hormonal regulation of single gb-
merular function [12, 131, it is possible to expect
that the effects of hormones (and other humoral
agents) on glomeruli may be mediated via cyclic
adenosine monophosphate (cAMP) or cGMP.
An integral part of cyclic nucleotide metabolism
is enzymatic hydrolysis of cyclic 3',5'-nucleotides
to 5'-nucleotides via action of cyclic 3',5'-nucle-
otide phosphodiesterases [1, 21; catabolism of cy-
clic nucleotides in glomeruli has not yet been inves-
tigated. In the present study, we therefore explored
whether the presence and properties of enzyme ac-
tivities catabolizing cAMP and cGMP in glomeruli
differ from that in tubules or unfractionated rat re-
nal cortex.
Methods
Tissues were obtained from Sprague-Dawley rats
weighing 180 to 280 g. After induction of pentobar-
bital anesthesia (50 mg/kg of body wt), a polyethyl-
ene catheter (PE-90) was inserted into the low ab-
dominal aorta immediately above the bifurcation.
Subsequently, the aorta was clamped above the
renal arteries, the renal veins were cut, and the kid-
neys were perfused with 60 to 80 ml of modified
Krebs-Ringer phosphate buffer (KRB) of the follow-
ing composition: 140 mrvt sodium chloride, 5 mM po-
tassium chloride, 1.2 m magnesium sulfate, 2.0
m calcium chloride, 10 ifiM glucose, 10 m so-
dium acetate, 2 m sodium phosphate, and 20 mM
Tris (pH, 7.4). The interval between clamping the
aorta and the onset of perfusion did not exceed 20
sec. After the kidney surfaces were completely
blanched, kidneys were removed and placed on ice.
The cortex was dissected from the kidney; a part
was used for preparation of glomeruli and tubules,
another part (in some experiments) for tissue slices.
Renal cortical slices (0.5 mm in thickness) were cut
with a Stadie-Riggs tissue slicer [14, 151 and washed
several times in KRB. Glomeruli and tubules were
prepared by using a combination of sieving and den-
sity gradient centrifugation (Fig. 1); some major
steps were adapted from the method by Nørgaard
[161. All preparative steps were performed at 4° C.
The cortical tissue was minced and passed through
a sieve and hypodermic needle as specified in detail
in Fig. 1. The resulting suspension of cortical tissue
was washed four times with the modified KRB to
eliminate debris and small tissue fragments. Sub-
sequently, the cortical tissue was fractionated by
centrifugation on a discontinuous Ficoll density gra-
dient [161; centrifugal force, time, and Ficoll con-
centrations are specified in Fig. 1. Glomeruli were
collected from the 11 to 20% and the 20 to 23% in-
terphase. The pellet at the bottom of the cuvette
contained large aggregates of tubular fragments,
which were retained on a nylon screen, as shown in
Fig. 1. These fragments were rinsed with 60 to 80 ml
of KRB to reduce glomerular contamination to a
negligible level. Glomerular and tubular fractions
were again washed three or four times by repeated
centrifugation at x l4Og for a period of 1.5 mm.
The purity of the gbomerular suspensions was
evaluated by light microscopic examination and
counting; only preparations containing more than
Cold KRB
50-100 ml
• Cortex dissected. Slices obtained.
• Cortex minced, passed through sieve 1220 pm
opening) and 23-gauge needle.


















Nylon screen, 400 pm opening I
Fig. 1. Diagrammatic summary of the method used for prepara-
tion of glomeruli and tubules. For further details see Methods.
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95% glomeruli were taken to the experiment. In ad-
dition to the microscopic examination, in some ex-
periments alkaline phosphatase activity in homoge-
nates from glomerular and tubular suspensions was
also measured. The specific activity of alkaline phos-
phatase was significantly higher in tubular prepara-
tions (tubules: 8.12 0.94; glomeruli: 2.69 0.54
1imoles!mg of protein per hour; N = 10; P < 0.001).
Homogenates and fractions were always pre-
pared simultaneously from glomeruli; tubules and
slices obtained from randomized renal cortical tis-
sues were pooled from two to four rats. Immediate-
ly after preparation, the washed glomeruli, tubules,
or tissue slices were homogenized in a polytef
pestle-glass homogenizer (size 0; clearance 0.05 to
0.1 mm; A. H. Thomas Co., Philadelphia, Pa.) using
five strokes. The homogenization medium had the
following composition: 0.25 M sucrose, 5 mi'vi Tris,
3 msi magnesium chloride; 1 mM ethylenediamine-
tetraacetic acid (EDTA) (pH, 7.4) (1:20 wet weight!
vol). Homogenization and all other preparative
procedures were conducted at 0 to 4° C. An aliquot
of the homogenate was frozen in dry ice. Another
aliquot of the homogenate was centrifuged at
X100,000g for 60 mm: the xlOO,000g supernate
(cytosol) was collected and frozen in dry ice. The
pellet was resuspended in the homogenization me-
dium (volume equal to original homogenate) and
centrifuged again at x 100,000g for 60 mm. The
washed pellet was resuspended in a small volume of
the homogenization medium and frozen in dry ice.
Homogenate, cytosol, or x 100,000g pellet (further
referred to as "membrane fraction") was quickly
frozen in tubes precooled in dry ice and were stored
in a deep-freeze chest (Revco Co.) at —80° C until
assayed for enzyme activities. Homogenate, cyto-
sol, and membrane fraction prepared simultaneous-
ly from the same pool of kidneys were always as-
sayed for enzyme activities at the same time with
the same biochemicals to minimize possible day-to-
day variation between assays and preparative pro-
cedures.
Assays. Alkaline phosphatase activity was mea-
sured as described in our previous report [171. The
protein content was determined by the method of
Lowry et al [18].
Activites of cyclic 3',5'-adenosine monophos-
phate diesterase (cAMP-PDIE) and cyclic 3' ,5'-
guanosine monophosphate diesterase (cGMP-PDIE)
[4] were assayed by incubating the homogenate
or fractions of homogenate (10 to 15 g of pro-
tein per tube) with substrates (with 1 M RH-cAMP
or with 1 M 3H-cGMP) in an incubation mixture
(total volume 200 .d) containing: 10 m magnesium
sulfate, 0.1 mrvi EDTA, and 50 msi Tris hydro-
chloric acid (PH, 8.0), unless specified otherwise. In
experiments in which the effects of agents on cyclic
nucleotide phosphodiesterase activities were in-
vestigated (summarized in Fig. 3 and in Table 1),
1 mM ethylene-bis-(oxyethylenenitrilo-)-tetraacetic
acid (EGTA) was also included in the incubation
mixture. In preliminary experiments, it was deter-
mined that addition of 1 mivi EGTA did not change
appreciably the specific activity of either cAMP-
PDIE or cGMP-PDIE. After a 20-mm incubation
period at 37° C, the reaction was stopped by heat-
ing at 95° C for 3 mm, and the 3H-5'-nucleotide prod-
ucts were converted to 3H-nucleosides by incuba-
tion with an excess of 5'-nucleotidase, as described
in previous reports [4, 14, 15, 17]. Enzymatic reac-
tion was linear with time for at least 25 mm. Nucleo-
sides were separated from nucleotides with use of
QAE-Sephadex columns according to the procedure
of Wells et al [19], as in our previous studies [4, 14,
15]. In preliminary experiments, it was determined
that enzyme reactions from glomeruli or tubuli (with
8H-cAMP or 3H-cGMP as a substrate) were linear
up to 30 pg of protein per tube. The enzyme activity
was expressed in picomoles of either cAMP or
cGMP hydrolyzed per minute per milligram of pro-
tein. The assays were run in triplicate. To ascertain
that freezing and thawing do not alter the enzyme
activities, in a control experiment we compared the
activities of cAMP-PDIE and cGMP-PDIE in ho-
mogenate x 100,000g supernate, in X l00,000g pellet
assayed in fresh (unfrozen) preparations, and in
aliquots of the same preparations subjected to
freezing and thawing as described above. We found
that the freezing and thawing procedure did not al-
ter the specific activities of either cAMP-PDIE or
cGMP-PDIE. Results were evaluated by Stu-
dent's t test for either group or paired comparisons
as appropriate (and as specified in the Results sec-
tion).
Materials. 3H-cAMP and 3H-cGMP were pur-
chased from New England Nuclear, Boston, Mass.;
Ficol and QAE-Sephadex, from Pharmacia Fine
Chemicals, Piscataway, N.J.: 1-methyl-3-isobutyl
xanthine (MIX), from Aldrich Chemical Co.; and 8-
(p-Cl-phenylthio)-cyclic 3' ,5'-guanosine mono-
phosphate (CIPheS-cGMP), from ICN Pharmaceu-
ticals, Inc., Life Science Group, Cleveland, Oh.
Other biochemicals and chemicals (of highest purity
grades) were purchased from standard suppliers.
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Results
The specific activities of cAMP-PDIE and cGMP-
PDIE were first examined in homogenates of gb-
meruli, tubules, and tissue slices (Fig. 2). In gb-
meruli, the specific activity of cGMP-PDIE was sig-
nificantly higher than that of cAMP-PDIE, but in
cortical tubules and slices of the same kidneys the
specific activity of cAMP-PDIE was significantly
higher than that of cGMP-PDIE. The specific activi-
ty of cGMP-PDIE was significantly higher in gbomer-
uli than it was in cortical tubules and slices. On
the other hand, the specific activity of cAMP-PDIE
was significantly higher in cortical tubules and
slices than it was in gbomeruli.
Next, we examined cAMP-PDIE and cGMP-
PDIE in soluble and particulate fractions of homog-
enates (Fig. 3). The specific activity of cGMP-PDIE
in all three preparations (glomeruli, tubules, and
slices) was higher in cytosol than it was in mem-
brane fractions (P < 0.05). On the other hand, the
specific activity of cAMP-PDIE in cytosol did not
significantly differ from that in the membrane frac-
tion in any of the three preparations. In accord with
our findings in unfractionated homogenates, the
specific activity of cGMP-PDIE in cytosol and
membrane fractions from glomeruli was significant-
ly higher than it was in analogous fractions from tu-
bules or slices.
The effects of some naturally occurring factors
(nucleotides or calcium) or some drugs known to
influence cyclic nucleotide phosphodiesterase ac-
tivities from other cellular systems [201 were tested
in soluble and particulate fractions, as well as in ho-
mogenates from both gbomeruli and tubules, as de-
scribed in the Methods section; in all the assays, I
mM EGTA was always included in the incubation
mixture.
The effect of free calcium (Ca2) on cyclic nude-
otide phosphodiesterases was tested by adding cal-
cium chloride into the incubation mixture in molar
excess of EGTA (1.010 m calcium chloride + 1
mM EGTA) to achieve a concentration of free cal-
Table!. Effects of nucleotides, calcium, and drugs on cyclic nucleotide phosphodiesterase activitya
Additions
Glomeruli Tubules
Cytosol Membrane fraction Cytosol Membrane fraction
Effect on cAtvtPphosphodiesterase
None 208.3 43.8 163.1 29.6 133.8 42.9 124.6 16.3
N (6) (6) (6) (6)
cGMP(5 X 1O6M) 407.7 44.4 270.9 43.6 134.5 43.4 134.4 12.7
N (6) (6) (6) (6)%b + 118.1 26.8 +74.3 19.lc +0.3 8.0 + 11.5 8.2
Calcium chloride(l05M) 214.7 35.9 180.8 36.9 154.1 46.0 123.0 14.0
N (6) (6) (6) (6)%b +8.8 4.8 +9.6 8.7 +0.1 3.8 +28.6 12.8
DibutyrylcAMP(l04M) 123.3 29.9 127.6 29.3 97.9 26.9 89.3 15.9
N (5) (5) (5) (5)%b —35.8 3.6c —23.9 47c —35.0 4.1 —32.4 2.8
Effect on cGMP phosphodiesterase
None 250.0 54.5 131.9 21.1 111.9 20.1 47.9 9.7
N (6) (6) (6) (5)
cAMP (5 x 106M) 220.1 45.7 118.5 19.5 102.7 22.3 42.8 10.6
N (6) (6) (6) (5)%b —10.6 2.4' 9.9 2.9c —9.9 4.1 —13.8 7.4
Calcium chloride (105M) 264.9 49.2 149.9 25.9 150.5 26.1 55.9 10.4
N (6) (6) (6) (5)%b + 14.0 8.3 + 14.4 5.2' +35.5 10.3 + 18.8 5. Ic
DibutyrylcAMP(104M) 227.2 57.1 117.6 2.8 109.9 22.3 41.9 10.1
N (6) (6) (6) (5)%b —14.1 6.5 —13.0 6.6 —3.7 4.2 —16.9 6.8
a Enzyme activities (both for cGMP-PDIE and cAMP-PDIE) are expressed in pmoles/min/mg of protein SEM. Numbers in parenthe-
ses denote number of observations. Differences were evaluated comparing the activity in the presence of added agent with basal activity
(no addition) measured in the same assay, using the same enzyme preparation by paired I test. As indicated in the Methods, all assay
mixtures include 1 m't EGTA.
bThis is a change (%) from basal activity.
Difference is significant at P < 0.05 or less.
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cAMP-PDIE by cGMP (results not shown). N6-02-
dibutyryl cyclic 3'-5'-AMP (DBcAMP) significantly
inhibited cAMP-PDIE in both glomeruli and tubules
(Table 1).
cAMP, but not DBcAMP, slightly but significant-
ly inhibited cGMP-PDIE in both soluble and mem-
brane-bound fractions from isolated glomeruli
(Table 1). The tubular cGMP-PDIE was not consis-
100 tently influenced by the addition of either cAMP or
DBcAMP. Glomerular cGMP-PDIE activity was
slightly but significantly increased by the presence
of free calcium only in membrane fractions; cGMP-
PDIE activity in both soluble and membrane-bound
fractions of tubules was significantly higher when
free calcium (in micromolar range, about 10 j.M)
was present (Table 1). Both cAMP-PDIE and
cGMP-PDIE activities from glomeruli and from tu-
Glomeruli
Fig. 2. Comparison of specific activities of cAMP-PDJE (A, open
bars) and cGMP-PDIE (G, shaded bars) in homogenates of
cortical slices, tubules, and glomeruli. Values represent mean
SEM of six experiments, each including preparations of slices,
tubules, and glomeruli from the same batch of kidneys. Asterisk
(*) denotes values in glomeruli different from those in tubules or
cortical slices (t test; P < 0.01).
cium in the mixture in a micromolar range [21—231.
Based on the estimated binding-constant of EGTA
for free calcium [22, 23], the concentration of free
calcium could deviate from this value depending on
pH and the protein content in the mixture.
Cyclic nucleotide phosphodiesterases from
glomeruli or tubules showed differences in the sen-
sitivity to cyclic nucleotides and to free calcium.
Cyclic AMP-PDIE from glomerular homogenate
(Fig. 4), or soluble and membrane fractions (Table
1), was significantly stimulated by the addition of
cGMP. This stimulatory effect of cGMP on cAMP-
PDIE was dose dependent (Fig. 4) and highly spe-
cific. The addition of 5 x 10-6 or 105M N6-02-di-
butyryl cyclic 3' ,5'-GMP, ClPhes-cGMP, cyclic
3' ,5'-inogine monophosphate, cyclic 3 '-5'-uridine
monophosphate, cyclic 3 '-5 '-cytidine monophos-
phate, or 5'-GMP had no stimulatory effects. Solu-
ble and membrane-bound cAMP-PDIE were stimu-
lated by cGMP to about the same extent (Table 1).
In contrast, cAMP-PDIE from tubules was not sig-
nificantly influenced by the addition of cGMP under
identical conditions (Fig. 4, Table 1). The addition
of calcium chloride to achieve a concentration of
free calcium in the micromolar range (about 10 ILM)
had no consistent effect on cAMP-PDIE activity
either in glomeruli or tubules (Table 1), nor did it
have any influence on the stimulation of glomerular








Cortical slices Tubules Glomsruli
Membrane fraction
(X100,000g pellet)
A -' A G A G
Cortical slices Tubules Glomeruli
Fig. 3. Specic activities of cAMP-PDIE (A, open bars) and
cGMP-PDIE (G, shaded bars) in cytosal (upper panel) and in
membrane fraction (xJOO,000g pellet, see Methods) (lower panel).
Values represent mean SEM of five experiments, each includ-
ing preparation of slices, tubules, and glomeruli. Single asterisk
(*) denotes value significantly different from that of tubules;
double asterisks (**) denotes activity significantly different from
tubules and cortical slices (P < 0.01; 1 test).
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100
0 L7.'i I I I I0 10 10 iO- 10
cGMP concentration, M
Fig. 4. Effects of various cGMP concentrations on cAMP-PDIE
in homogenates from glomeruli (solid line) and tubules (broken
line). Each dose-response curve is representative of three dif-
ferent experiments.
bules were profoundly inhibited (mean change, at
least 65% or more) by MIX (l0-4M) or by papave-
rifle (104M); papaverine was in most instances a
more effective inhibitor than MIX was (data not
shown).
Discussion
The present results demonstrate that glomeruli
are characterized by a high specific activity of
cGMP-PDIE in comparison with tubules and un-
separated renal cortex. In conjunction with reports
of a high amount of immunoreactive cGMP [7] and
a high specific activity of glomerular guanylate cy-
clase [8] the present results suggest that cGMP me-
tabolism is particularly active in glomeruli. On the
other hand, cAMP-PDIE activity seems to prevail
in tubules. It is not surprising that the ratio of
cAMP-PDIE to cGMP-PDIE specific activities in
tubules resembles that in unfractionated cortex
(Fig. 2); glomeruli represent only about 8% of cor-
tical tissue [6].
Glomerular and tubular cGMP-PDIE and cAMP-
PDIE also differ with respect to their sensitivity to
agents known to modulate cyclic nucleotide metab-
olism. A specific sensitivity of glomerular cAMP-
PDIE to stimulation by cGMP (Table 1, Fig. 2) is of
particular interest. Concent]rations of cGMP in
glomeruli are apparently higher than they are in tu-
bules [7, 24], and they could be increased, for ex-
ample, by cholinergic agents [241. Since cAMP me-
tabolism in glomeruli is likely to be under hormonal
control [7, 9, 10, 11], it appears that cAMP-mediat-
ed responses to hormones in glomeruli could be at-
tenuated or accentuated by changing concentra-
tions of cGMP. In tubules, the modulatory effects of
cGMP on the cAMP system were not detected in
the present study.a
It is noteworthy that N6-02-dibutyryl cyclic 3',S'-
GMP and C1PheS-cGMP, two analogs which are
used to duplicate biological cGMP effects, were in-
active in terms of stimulating cAMP hydrolysis,
suggesting that they could not be utilized experi-
mentally to mimic the stimulatory effect of cGMP
on cAMP hydrolysis. DBcAMP was found to inhibit
cAMP-PDIE, suggesting that in glomeruli, as in ren-
al medulla [15], the effects of DBcAMP to increase
endogenous cAMP concentrations may be due in
part to the attenuation of cAMP breakdown.
In contrast to cAMP-PDIE, cGMP-PDIE is
slightly inhibited rather than stimulated by cAMP;
DB-cAMP did not inhibit cGMP-PDIE consistently,
stressing again that DBcAMP does not always du-
plicate the intracellular effects of cAMP by acting as
a biologically active analog of native cAMP [15].
Free calcium, acting probably via an activator
protein [26], has been previously shown to increase
cyclic nucleotide phosphodiesterase activities in
various preparations from the whole kidney [21] or
kidney cortex [27]. In our preparations, free cal-
cium in micromolar range (about 10 LM) stimulated
only cGMP-PDIE from the tubules, but the effect
on glomerular cGMP-PDIE was significant only in
the membrane fraction. Cyclic AMP-PDIE was not
influenced by added free calcium either in glomeruli
or tubules. These observations suggest that changes














a Filburn, Liang, and Sacktor [25] reported recently that
cAMP hydrolysis in the fraction containing basal-lateral mem-
branes prepared from rabbit renal cortex was stimulated by
cGMP. This apparent discrepancy from our results could be due
to species difference but also to the fact that the basal-lateral
membrane fraction was prepared from the whole cortex and
hence could contain an admixture of glomerular membranes. The
latter possibility seems supported by our observation that
cAMP-PDIE in membrane fraction from the unfractionated cor-
tical slices was slightly stimulated by cGMP. This effect of 5 x
106M cGMP (increase % + 29.1 7.5; N = 7; P < 0.02) was
markedly lower (P < 0.05) than that in analogous preparation
from glomeruli (see Table 1).
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are likely to increase cGMP catabolism in tubules
but not in glomeriili, at least not to the same extent.
The exact relation, however, between free calcium
concentration and activation of cGMP-PDIE re-
mains to be established. It should be realized that
the extent of the free calcium effect may be also de-
pendent on the activator protein [261, the presence
and quantity of which in glomeruli and tubules are
presently not known.
Comparing activities and properties of cyclic nu-
cleotide phosphodiesterases in glonieruli and tu-
bules, it should be realized that cortical tubules—in
contrast to glomeruli—are a much more hetero-
genous mixture of different tubular segments of
nephron [6], and further fractionation of various
tubular types could reveal another difference in this
respect.
While multiple differences were observed be-
tween cyclic nucleotide phosphodiesterases (both
in terms of activities and properties) from glomeruli
and tubules, there were few differences in the
gross subcellular distribution of these enzymes be-
tween cytosol and membrane fractions. The distri-
bution of cyclic nucleotide phosphodiesterases be-
tween soluble and particulate fractions of kidney
cortex homogenates can be influenced by the vigor-
ousness of mechanical homogenization [281, the
composition of homogenization medium, or the dif-
ference between animal species examined [2, 4, 27—
30]. The mild homogenization conditions used in
our present experiments probably caused the rather
high (relative to cytosol) cAM P-PDIE activity in the
pellet (Fig. 3). The specific activity of cGMP-PDIE
(under identical conditions) was always significant-
ly higher in cytosol than it was in the pellet (Fig. 3);
this finding suggests that cGMP-PDIE is more abun-
dant in the cytoplasm or that it is less tightly associ-
ated with membrane material than cAMP-PDIE is.
Much useful information has been obtained by
studying cyclic nucleotide phosphodiesterases in
preparations from whole cortex [2, 4, 25, 27, 28, 30]
or from the whole kidney [21, 29, 30, 31]. Results of
this study, however, show that specific activities and
properties of cAMP-PDIE and cGMP-PDIE differ
in specialized structures within the renal cortex and
that glomerular cyclic nucleotide catabolism may
substantially differ from other parts of the nephron.
Thus, it is critically important to investigate the en-
zymes of cyclic nucleotide metabolism directly in
isolated individual structural units of the nephron.
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